HNB
QNRX

Huntington National Bank’s Quoin Pharmaceuticals QNRX Stock Holding History

Huntington National Bank’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6 Hold
1
– – ﹤0.01% 4049
2026
Q1 		$6 Hold
1
– – ﹤0.01% 3887
2025
Q4 		$6 Hold
1
– – ﹤0.01% 3801
2025
Q3 		$6 Hold
1
– – ﹤0.01% 3830
2025
Q2 		$6 Buy
+1
New +$8 ﹤0.01% 3836
2025
Q1 		– Hold
0
– – – 3847
2024
Q4 		– Hold
0
– – – 3858
2024
Q3 		– Hold
0
– – – 3851
2024
Q2 		– Hold
0
– – – 3798
2024
Q1 		– Hold
0
– – – 3672
2023
Q4 		– Hold
0
– – – 3575
2023
Q3 		– Hold
0
– – – 3548
2023
Q2 		– Hold
0
– – – 3504
2023
Q1 		– Hold
0
– – – 3366
2022
Q4 		– Hold
0
– – – 3234
2022
Q3 		– Hold
0
– – – 2317
2022
Q2 		– Hold
0
– – – 2344
2022
Q1 		– Hold
0
– – – 2298
2021
Q4 		– Hold
0
– – – 2251
2021
Q3 		– Hold
0
– – – 1690

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Huntington National Bank's QNRX Position: Q2 2026 in Review

Huntington National Bank held its Quoin Pharmaceuticals (QNRX) position steady in Q2 2026 at 1 share worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #4049.

Huntington National Bank first reported a position in QNRX in Q2 2025 and has held it in 5 quarters since. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Huntington National Bank held 1 share of Quoin Pharmaceuticals worth $6 as of Q2 2026.
  • Huntington National Bank left its Quoin Pharmaceuticals share count unchanged in Q2 2026.
  • Quoin Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #4049 holding.
  • Huntington National Bank first reported a position in Quoin Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.